Freeox Biotech

Developer of therapies for treating ischaemic stroke

placeBarcelona, Catalonia, Spain calendar_todayFounded 2017 groups2 employees language freeoxbiotech.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace active. Cited 14 times.

YearFilings
20251

Social engagement

Social engagement: 678 social following, 7 posts in the last 12 months — above the industry median.

Investor mix

4 investors on record.

Investor typeCountShare
Accelerator & incubator125%
Other / undisclosed375%

Recent activity

15 Dec 2025
Event
Meet the CEOs
8 Dec 2025
Event
Ox-01 - a first-in-class cerebroprotective therapy currently advancing toward a Phase 2b/3 trial supported by NINDS/NIH
2 Dec 2025
Event
Breakfast Brain Protective Therapy Webinar
Coming soon